Phosphodiesterase 3 Inhibitors
- Name
- Phosphodiesterase 3 Inhibitors
- Accession Number
- DBCAT000590
- Description
Compounds that specifically inhibit PHOSPHODIESTERASE 3.
- Drugs
Drug Drug Description Milrinone A PDE-III inhibitor with inotropic, lusitropic, and vasodilatory properties used for the short-term treatment of acute decompensated heart failure. Cilostazol An antiplatelet agent and vasodilator used for the symptomatic relief of intermittent claudication. Amrinone A positive inotropic agent and phosphodiesterase inhibitor used in the management of treatment of congestive heart failure. Enoximone A selective phosphodiesterase inhibitor indicated in the short term treatment of congestive heart failure. Anagrelide A platelet-reducing agent used to treat thrombocythemia, and its related complications, secondary to myeloproliferative neoplasms. Levosimendan A calcium sensitizer indicated to treat acutely decompensated severe chronic heart failure. Simendan Simendan is under investigation in clinical trial NCT00527059 (Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure). Olprinone Not Annotated - Drugs & Drug Targets